Skip to main content
Log in

Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA

Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine

  • Intestinal Disorders, Inflammatory Bowel Disease, Immunology, and Microbiology
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Endoscopic biopsies are being increasingly utilized to investigate cytokine profiles in normal and diseased intestine. To evaluate the adequacy of mucosal biopsies as a source of cytokine-specific mRNA, we measured their content of interleukin-1β (IL-1β) and interleukin-2 (IL-2) mRNA by reverse transcription-polymerase chain reaction and compared it to that of autologous lamina propria mononuclear cells in control and inflammatory bowel disease-involved specimens. High-quality total RNA was recovered more consistently from cell isolates than from biopsies. Interleukin-1β mRNA was reliably detected in both cell and biopsy samples, whereas IL-2 mRNA was measurable in all lamina propria cells but not always in biopsies. Compared to controls, levels of IL-1β were significantly elevated in Crohn's disease and ulcerative colitis cells and biopsies, and a weak but significant correlation existed between values derived from the two sources. In contrast, only ulcerative colitis cell isolates but not biopsies contained significantly reduced concentrations of IL-2 mRNA compared to those of control and Crohn's disease samples, and no correlation was found between cell and biopsy contents. Widely different levels of cytokine-specific mRNA were present in closely adjacent biopsies, particularly for IL-2. These results suggest that mucosal biopsies are suitable to assess some but not all cytokine-specific mRNA due to variation in RNA recovery, intrinsic level of cytokine gene expression, and substantial variability of cytokine transcripts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fiocchi C: Pathophysiology: Facts, hopes and implications for treatment.In Inflammatory Bowel Disease: Pathophysiology as Basis of Treatment. J Scholmerich, W Kruis, H Goebell, W Hohenberger, V Gross (eds). Lancaster, Kluwer Academic, 1993, pp 257–279

    Google Scholar 

  2. Fiocchi C: Cytokines.In Inflammatory Bowel Disease. From Bench to Bedside. SR Targan, F Shanahan (eds). Baltimore, Williams & Wilkins, 1994, pp 106–122

    Google Scholar 

  3. Paul WE: Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 57:521–524, 1989

    Google Scholar 

  4. Erlich HA, Gelfand DH, Saiki RK: Specific DNA amplification. Nature 331:461–462, 1988

    Google Scholar 

  5. Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH: Interleukin 2 activity of human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 86:734–742, 1984

    Google Scholar 

  6. Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR: Interferon γ production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci 33:1528–1536, 1988

    Google Scholar 

  7. Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP: Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102:1620–1627, 1992

    Google Scholar 

  8. Salomon P, Pizzimenti A, Panja A, Reisman A, Mayer L: The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium. Autoimmunity 9:141–149, 1991

    Google Scholar 

  9. MacDonald TT, Hutchings P, Choy M-Y, Murch S, Cooke A: Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301–305, 1990

    Google Scholar 

  10. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT: Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127–131, 1993

    Google Scholar 

  11. Wang AM, Doyle MV, Mark DF: Quantification of mRNA by polymerase chain reaction. Proc Natl Acad Sci USA 86:9717–9721, 1989

    Google Scholar 

  12. Siebert PD, Larrick JW: Competitive PCR. Nature 359:557–558, 1992

    Google Scholar 

  13. Fiocchi C: Cytokines.In Inflammatory Bowel Disease. RP MacDermott, W Stenson (eds). New York, Elsevier, 1992, pp 137–162

    Google Scholar 

  14. Fiocchi C, Battisto JR, Farmer RG: Gut mucosal lymphocytes in inflammatory bowel disease. Isolation and preliminary functional characterization. Dig Dis Sci 24:705–717, 1979

    Google Scholar 

  15. Matsuura T, West GA, Youngman KR, Klein JS, Fiocchi C: Immune activation genes in inflammatory bowel disease. Gastroenterology 104:448–458, 1993

    Google Scholar 

  16. Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiocchi C: Localization of intestinal interleukin 1 activity, protein and gene expression to lamina propria cells. Gastroenterology 104:749–758, 1993

    Google Scholar 

  17. Strober W, Ehrhardt RO: Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203–205, 1993

    Google Scholar 

  18. Kusugami K, Matsuura T, West GA, Youngman KR, Rachmilewitz D, Fiocchi C: Loss of interleukin-2-producing intestinal CD4+T cells in inflammatory bowel disease. Gastroenterology 101:1594–1605, 1991

    Google Scholar 

  19. Matsuura T, West GA, Klein JS, Ferraris L, Fiocchi C: Soluble interleukin 2, CD8 and CD4 receptors in inflammatory bowel disease. A comparative study of peripheral blood and intestinal mucosal levels. Gastroenterology 102:2006–2014, 1992

    Google Scholar 

  20. Mahida YR, Gallagher A, Kurlak L, Hawkey CJ: Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 82:75–80, 1990

    Google Scholar 

  21. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 31:686–689, 1990

    Google Scholar 

  22. Brynskov J, Tvede N, Andersen CB, Vilien M: Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopic mucosal biopsies specimens with active inflammatory bowel disease. Gut 33:55–58, 1992

    Google Scholar 

  23. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB: Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37:818–826, 1992

    Google Scholar 

  24. Isaacs KL, Sartor RB, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103:1587–1595, 1992

    Google Scholar 

  25. Mullin GE, Vezza FR, Sampat A, Maycon Z, Katz R, Eisenstein E, Weissman G, McKinley M, Fisher SE: Abnormal IL-10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 104:A751, 1993

    Google Scholar 

  26. Dinarello CA, Wolf SM: The role of interleukin-1 in disease. N Engl J Med 328:106–113, 1993

    Google Scholar 

  27. Smith KA: Interleukin-2: Inception, impact, and implications. Science 240:1169–1176, 1988

    Google Scholar 

  28. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn's disease. Gut 30:835–838, 1989

    Google Scholar 

  29. MacDermott RP, Franklin GO, Jenkins KM, Kodner IJ, Nash GS, Weinrieb IJ: Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities. Gastroenterology 78:47–56, 1980

    Google Scholar 

  30. Selby WS, Janossy G, Bofill M, Jewell DP: Intestinal lymphocyte subpopulations in inflammatory bowel disease: An analysis by immunohistological and cell isolation techniques. Gut 25:32–40, 1984

    Google Scholar 

  31. James SP, Fiocchi C, Graeff AS, Strober W: Phenotypic analysis of lamina propria lymphocytes. Gastroenterology 91:1483–1489, 1986

    Google Scholar 

  32. Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME: Microscopic activity in ulcerative colitis: What does it mean? Gut 32:174–178, 1991

    Google Scholar 

  33. Radford-Smith G, McGowan I, Keshav S, Jewell DP: Investigation of cytokine mRNA production in the normal human intestinal mucosa. Gastroenterology 106:A757, 1994

    Google Scholar 

  34. Khoo UY, Hunter RL, Peakman M, Forgacs I, Bjarnson I, Macpherson AJS: The distribution of human intestinal lymphocytes changes with site and differs from the periphery. Gastroenterology 106:A711, 1994

    Google Scholar 

  35. Blumberg RS, Yockey C, Balk SP: Oligoclonal expansion of human intestinal αβ T lymphocytes in epithelium and lamina propria. Gastroenterology A102:597, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by a grant (DK 30399) from the National Institutes of Health (NIDDK).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukushima, K., West, G. & Fiocchi, C. Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Digest Dis Sci 40, 1498–1505 (1995). https://doi.org/10.1007/BF02285198

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02285198

Key Words

Navigation